Recent data has suggested that familial recurrent hydatidiform mole is a rare autosomal recessive trait in women experiencing this gestational disease (MIM 231090). Here we provide molecular data on an additional family confirming that recurrent familial hydatidiform moles are diploid, biparental and arise from independent conceptions. A narrowing of the gene interval on chromosome 19q13.3-13.4 is suggested by haplotype analysis in two sisters.
Introduction
Hydatidiform mole (HD) can be defined simply as a human conceptus displaying macroscopically visible vesicular villi and trophoblastic hyperplasia. 1 Recurrence of molecular pregnancies is rare (1-5%), [2] [3] [4] [5] but after two episodes the risk rises to 11-30%. [3] [4] [5] Familial HM (MIM 231090) is exceedingly rare, with only seven families having been reported so far. [6] [7] [8] [9] [10] [11] Consanguinity was often noted between the partners, suggesting an autosomal recessive etiology in the conceptus genotype. 10 Recently Helwani et al 12 reported a family in which consanguinity was also noted between the parents of the women. This finding together with biparentality of the moles in this family prompted that group to consider an autosomal recessive genotype in the woman. 
Materials and methods

Subjects and materials
A couple from a mountain region of Southern Italy sought genetic counselling for familial recurrence of hydatidiform moles ( Figure 1 ). The proband and her partner are first cousins, while the proband's sister and partner were second cousins. Consanguinity between the proband's parents is not reported, although both come from the same village. The proband experienced eight reproductive failures (from the age of 28 to 37), including six complete moles (with histopathologic documentation) and two miscarriages in the first gestational trimester. The seventh pregnancy (HM V:11) was attempted by ovum donation, but STS analysis, and HLA molecular typing of the molar conceptus established that it was originated by the fertilisation of a maternal ovum (HLA data are not shown). This mole was persistent and treated with methotrexate. The proband's sister reported the recurrence of three molar pregnancies (from the age of 25 to 32).
Ploidy assessment of molar tissues
One molar sample (HM V:11) was studied by standard karyotype and flow cytometry, while a previous molar conceptus (HM V:10), was recovered as a paraffin embedded sample and studied only by flow cytometry.
Molecular analysis
Parental origin of two molar conceptuses was assessed by STS analysis, PCR amplification, PAGE and silver staining detection. A total of 17 microsatellite markers (D7S481, D7S507, D7S636, D7S523, D7S500, D7S550, D11S911, D14S283, D14S77, D14S267, D15S97, D15S211, D15S126, D15S11, GABRB3, D15S113, D15S210), obtained from the Genome Database, were tested to assess parental origin of HM V:11. Eight of the informative markers were used to analyse HM V:10. The chromosome 19 haplotypes, corresponding to the region where the locus responsible for familial HM was mapped, were also assessed in the two sisters by the same methods ( Figure 2 ). HLA data are not shown, but biparentality of HM V:11 was confirmed.
Results
Karyotype of trophoblastic tissue from HM V:11 showed diploidy. The cytofluorimetric analysis of both the molar tissues available confirmed diploidy for HM V:11 and assessed diploidy for HM V:10.
The results of the informative STS polymorphism analysis in two molar conceptuses of the proband are shown in Table 1 . Both samples showed biparentality for all the tested chromosomes. It was established that the two molar tissues examined originated from independent conceptions.
The two sisters with recurrent molar pregnancies shared both haplotypes in the investigated region. The inherited paternal and maternal haplotypes were identical, except for the locus D19S418 where both sisters were heterozygous (Figure 2 ).
Discussion
The etiology of sporadic and familial biparental diploid moles is completely unknown. A careful revision of the families reported [6] [7] [8] [9] [10] [11] [12] suggests an autosomal recessive genotype of women experiencing recurrent familial molar pregnancies, as proposed by Helwani et al. 12 Only one family has Candidate region for mole maker phenotype y been studied by molecular methods so far. 1 In this family the recurrent molar pregnancies demonstrated a biparental diploid chromosomal constitution. The data reported here confirm that in an independent family of different ethnic origin, recurrent familial molar pregnancies are biparental, diploid and derive from independent conceptions. The hypothesis of a mole-maker phenotype, due to homozygous genotype for autosomal recessive mutations in the women experiencing recurrent HMs, is supported in this family by the finding in two sisters of high recurrence of HM in the absence of normal pregnancies (Figure 1) .
Sharing of both chromosome 19 haplotypes by the two sisters is in accordance with the localisation of the gene indicated by Moglabey et al. 1 Interestingly, the two sisters were homozygous for the whole haplotype, excepted for the D19S418 locus. This extended homozygosity supports the hypothesis of a common ancestor for the parents, while the heterozygosity at the most centromeric marker suggests a narrowing of 2.8 cM of the candidate region proposed by Moglabey.
1
The 19q13.3-13.4 region is very densely endowed with genes and has been suggested to harbour imprinted genes. 1 Considering the etiology of sporadic partial and complete moles it should be possible that the imprinting phenomenon is also involved in familial HM. However, in sporadic holandric or tryploid HM probably more than one imprinted chromosomal region plays a pathogenetic role, whilst in familial HM it is likely that a single gene or chromosomal region is involved. If an imprinting centre or an imprinted gene were involved, a homozygous mutation in the maternal genotype would not be required and a heterozygous woman should be able to produce with equal probability normal and molar conceptuses depending on the inherited haplotype.
We are inclined to believe that an imprintor gene 13 is involved in the etiology of familial HM: a homozygous mutation in such a gene could disrupt the maternal imprinting in one or several chromosomal regions, mimicking a paternal double contribution. Although not knowing the exact timing of human imprinting, we do know, however, that somatic imprinting has to be erased in the germline and substituted with a gamete specific pattern. Some evidences from mice studies 14 indicate that specific methylation of H19 is already evident in meiotic prophase of the female germline: it is therefore possible that recessive mutations in imprinting regulator or effector genes of a woman cause an imprinting disruption in the ovum through an epigenetic modification.
We should also consider an alternative hypothesis not involving genomic imprinting: as an example, the molecular defect could be located in the complex process of foetoplacentation, regulated by complementary pairs of adhesion and receptorial molecules in maternal and trophoblast cells. 15, 16 In this regard the CD33L gene, mapped in the 19q13 region by FISH, could prove to be an interesting candidate. It is specifically expressed in the placenta and is likely to be associated with cell-cell interaction. 17 The identification of the gene could be of great general theoretical interest, but also of practical value for the women suffering from this rare condition. In fact, if an epigenetic effect on the conceptus genome were confirmed, an ovum donation (where allowed) could be effective in solving the problem. Otherwise, if the defect lies in some other molecule with a pivotal role in the regulation of decidual-trophoblast relations, then recurrent hydatidiform moles should equally arise, independently from the conceptus genome. 
